BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:27 PM
 | 
May 21, 2007
 |  BC Extra  |  Top Story

GSK down on Avandia data

GlaxoSmithKline (LSE:GSK; GSK) fell 81p to 1,383p on Monday after the New England Journal of Medicine published a meta-analysis of 42 clinical studies that showed an association between the use of Avandia rosiglitazone to treat Type II diabetes and increased risk of myocardial infarction (MI) and death from cardiovascular causes. The paper, by the Cleveland Clinic's Steven Nissen and Kathy Wolski, reported that Avandia was...

Read the full 317 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >